These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19679463)

  • 1. Screening of anti-glioma effects induced by sigma-1 receptor ligands: potential new use for old anti-psychiatric medicines.
    Mégalizzi V; Decaestecker C; Debeir O; Spiegl-Kreinecker S; Berger W; Lefranc F; Kast RE; Kiss R
    Eur J Cancer; 2009 Nov; 45(16):2893-905. PubMed ID: 19679463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines.
    Crawford KW; Bowen WD
    Cancer Res; 2002 Jan; 62(1):313-22. PubMed ID: 11782394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lactosylated steroid contributes in vivo therapeutic benefits in experimental models of mouse lymphoma and human glioblastoma.
    Ingrassia L; Nshimyumukiza P; Dewelle J; Lefranc F; Wlodarczak L; Thomas S; Dielie G; Chiron C; Zedde C; Tisnès P; van Soest R; Braekman JC; Darro F; Kiss R
    J Med Chem; 2006 Mar; 49(5):1800-7. PubMed ID: 16509595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs.
    Mégalizzi V; Mathieu V; Mijatovic T; Gailly P; Debeir O; De Neve N; Van Damme M; Bontempi G; Haibe-Kains B; Decaestecker C; Kondo Y; Kiss R; Lefranc F
    Neoplasia; 2007 May; 9(5):358-69. PubMed ID: 17534441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
    Vilner BJ; John CS; Bowen WD
    Cancer Res; 1995 Jan; 55(2):408-13. PubMed ID: 7812973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor compound testing in glioblastoma organotypic brain cultures.
    Biggs T; Foreman J; Sundstrom L; Regenass U; Lehembre F
    J Biomol Screen; 2011 Sep; 16(8):805-17. PubMed ID: 21807962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
    Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP
    Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo.
    Spruce BA; Campbell LA; McTavish N; Cooper MA; Appleyard MV; O'Neill M; Howie J; Samson J; Watt S; Murray K; McLean D; Leslie NR; Safrany ST; Ferguson MJ; Peters JA; Prescott AR; Box G; Hayes A; Nutley B; Raynaud F; Downes CP; Lambert JJ; Thompson AM; Eccles S
    Cancer Res; 2004 Jul; 64(14):4875-86. PubMed ID: 15256458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.
    John CS; Vilner BJ; Geyer BC; Moody T; Bowen WD
    Cancer Res; 1999 Sep; 59(18):4578-83. PubMed ID: 10493511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
    Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diazepam enhances hypericin-induced photocytotoxicity and apoptosis in human glioblastoma cells.
    Sarissky M; Lavicka J; Kocanová S; Sulla I; Mirossay A; Miskovsky P; Gajdos M; Mojzis J; Mirossay L
    Neoplasma; 2005; 52(4):352-9. PubMed ID: 16059654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
    Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
    Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells.
    Hui AM; Zhang W; Chen W; Xi D; Purow B; Friedman GC; Fine HA
    Cancer Res; 2004 Dec; 64(24):9115-23. PubMed ID: 15604281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Betulin elicits anti-cancer effects in tumour primary cultures and cell lines in vitro.
    Rzeski W; Stepulak A; Szymański M; Juszczak M; Grabarska A; Sifringer M; Kaczor J; Kandefer-Szerszeń M
    Basic Clin Pharmacol Toxicol; 2009 Dec; 105(6):425-32. PubMed ID: 19821831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGF receptor inhibitors in the treatment of glioblastoma multiform: old clinical allies and newly emerging therapeutic concepts.
    Gadji M; Crous AM; Fortin D; Krcek J; Torchia M; Mai S; Drouin R; Klonisch T
    Eur J Pharmacol; 2009 Dec; 625(1-3):23-30. PubMed ID: 19836372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors.
    Dhandapani KM; Mahesh VB; Brann DW
    J Neurochem; 2007 Jul; 102(2):522-38. PubMed ID: 17596214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class.
    Kilic T; Alberta JA; Zdunek PR; Acar M; Iannarelli P; O'Reilly T; Buchdunger E; Black PM; Stiles CD
    Cancer Res; 2000 Sep; 60(18):5143-50. PubMed ID: 11016641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
    Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
    J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.